DGAP-News: BB Biotech AG publishes its 2018 annual report

DGAP-News: BB BIOTECH AG / Key word(s): Annual Results

BB Biotech AG publishes its 2018 annual report

15.02.2019 / 07:00

The issuer is solely responsible for the content of this announcement.

Media release as of February 15, 2019

Annual report of BB Biotech AG as of December 31, 2018


BB Biotech AG publishes its 2018 annual report


BB Biotech AG published its annual report for fiscal year 2018 today. Besides the audited consolidated financial statements, the annual report contains detailed information on the biotechnology sector, BB Biotech's positioning, the investment areas covered by its portfolio and the companies it is invested in.

BB Biotech performed well last year in a challenging stock market environment. Although its total return was a negative -5.2% in CHF (-2.2% in EUR), this was much better than the portfolio performance of -14.5% in CHF and -11.1% in EUR, which reflects the high level of confidence shareholders have in BB Biotech. Consolidated and audited full year 2018 data showed a net loss of CHF 471 mn compared to a net gain of CHF 688 mn for the full year of 2017.

As already announced on January 18, 2019, BB Biotech will propose an ordinary dividend of CHF 3.05 per share at the upcoming Annual General Meeting, which represents a yield of 5% based on the volume-weighted average price of BB Biotech shares in December 2018. This marks a continuation of the dividend policy as introduced in 2013.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Январь 2022    »